Form D · Biotechnology
VIRxSYS Corp
Gaithersburg, MD · CIK 0001081596
Offering snapshot reported Dec 22, 2011 · SEC filing
- Reported sold
- $1000K Offering amount: $30M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Nov 10, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 22, 2011 | Initial | $999,999 | No comparison | 10 | SEC filing |
| Apr 7, 2011 | Amendment | $33,814,349 | $24,006,433vs Apr 12, 2010 | 276 | SEC filing |
| Apr 12, 2010 | Amendment | $9,807,916 | $0vs Nov 4, 2009 | 114 | SEC filing |
| Nov 4, 2009 | Initial | $9,807,916 | No comparison | 114 | SEC filing |
| Oct 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 18, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $2.7M (estimated)
- Finders' fees
- $250K (estimated)
- Form D file number
- 021-170591
The sales commissions and finders' fees above do not include an additional amount of up to 2% of the total offering for expenses related to the offering, including travel, meeting and other such costs.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Signature Capital Securities LLC | 43557 |
Source: Form D, filed Dec 22, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Ackmann | Executive |
| Helmer Agersborg | Director |
| Gerard Fleury | Executive |
| James Kehoe | Director |
| William Mc Intosh | Director |
| Lawrence Michaelis | Director, Executive |
| John Phair | Director |
| Riku Rautsola | Director, Executive |
| Franz Schmadl | Director |
| William Sick | Director |
| William Turner | Director |
| Prince Zachariah | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 Perry Parkway Suite 1 A
Gaithersburg, MD, 20877
Gaithersburg, MD, 20877